Clinical Pharmacokinetics in Monitoring Chronic Medication with Anti-Epileptic Drugs
Authors:
- 1 January 1975
- book chapter
- Published by Springer Nature
- p. 11-33
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Statistical Analysis of Pharmacokinetic Parameters in Epileptic Patients Chronically Treated with Anti-Epileptic Drugs1975
- Patient ComplianceNew England Journal of Medicine, 1973
- Pharmacokinetic study of a patient with diphenylhydantoin toxicityClinical Pharmacology & Therapeutics, 1973
- Kinetics of diphenylhydantoin elimination in ratsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Effect of dosage increments on blood phenytoin concentrationsJournal of Neurology, Neurosurgery & Psychiatry, 1972
- PHYSIOLOGICAL AND PHYSICOCHEMICAL BASES OF DRUG INTERACTIONS IN MAN*Annals of the New York Academy of Sciences, 1971
- Carbamazepine‐induced acceleration of diphenylhydantoin and warfarin metabolism in manClinical Pharmacology & Therapeutics, 1971
- Metabolic disposition of diphenylhydantoin in normal human subiects following intravenous administrationClinical Pharmacology & Therapeutics, 1969
- Sulthiame (Ospolot®) as Inhibitor of Diphenylhydantoin MetabolismEpilepsia, 1968
- The entry, accumulation and binding of diphenylhydantoin-2-C14 in brain Studies on adult, immature and hypercapnic catsInternational Journal of Neuropharmacology, 1963